Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction

被引:295
|
作者
Reddy, PH
Mani, G
Park, BS
Jacques, J
Murdoch, G
Whetsell, W
Kaye, J
Manczak, M
机构
[1] Oregon Hlth & Sci Univ, Neurogenet Lab, Inst Neurol Sci, Beaverton, OR 97006 USA
[2] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
[4] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
关键词
synaptopodin; synaptophysin; Alzheimer's disease; synaptic protein; cognitive decline;
D O I
10.3233/jad-2005-7203
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The objective of our research was to determine synaptic protein levels in brain specimens from AD subjects and age-matched control subjects. Further, to determine whether presynaptic or postsynaptic compartments of neurons are preferentially affected in AD patients, we studied 3 presynaptic vesicle proteins (synaptotagmin, synaptophysin, and Rab 3A), 2 synaptic membrane proteins (Gap 43 and synaptobrevin), and 2 postsynaptic proteins (neurogranin and synaptopodin) in specimens from AD and age-matched control brains. Two brain regions - the frontal and parietal cortices - were assessed for protein levels by immunoblotting analysis. We found a loss of both presynaptic vesicle proteins and postsynaptic proteins in all brain specimens from AD patients compared to those from age-matched control subjects. Further, we found that the loss of synaptic proteins was more severe in the frontal cortex brain specimens than in the parietal cortex brain specimens from the AD subjects compared to those from the control subjects, suggesting that the frontal brain may be critical for synaptic function in AD. Using immunohistochemistry techniques, we also determined the distribution pattern of all synaptic proteins in both the frontal and parietal cortices brain specimens from control subjects. Of the 7 synaptic proteins studied, the presynaptic proteins synaptophysin and rab 3A and the postsynaptic protein synaptopodin were the most down-regulated. Our study suggests that postsynaptic proteins and presynaptic proteins are important for synaptic function and may be related to cognitive impairments in AD.
引用
收藏
页码:103 / 117
页数:15
相关论文
共 50 条
  • [21] Is synaptic loss a unique hallmark of Alzheimer's disease?
    Scheff, Stephen W.
    Neltner, Janna H.
    Nelson, Peter T.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2014, 88 (04) : 517 - 528
  • [22] Compensating for thalamocortical synaptic loss in Alzheimer's disease
    Abuhassan, Kamal
    Coyle, Damien
    Maguire, Liam
    [J]. FRONTIERS IN COMPUTATIONAL NEUROSCIENCE, 2014, 8
  • [23] Nanoscale reorganisation of synaptic proteins in Alzheimer's disease
    Zhu, Wang-Hui
    Yang, Xiao-Xu
    Gou, Xu-Zhuo
    Fu, Shu-Mei
    Chen, Jia-Hui
    Gao, Feng
    Shen, Yong
    Bi, Dan-lei
    Tang, Ai-Hui
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2023, 49 (04)
  • [24] Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer's disease
    Wang, Jie
    Huang, Qi
    Chen, Xing
    You, Zhiwen
    He, Kun
    Guo, Qihao
    Huang, Yiyun
    Yang, Yang
    Lin, Zengping
    Guo, Tengfei
    Zhao, Jun
    Guan, Yihui
    Li, Binyin
    Xie, Fang
    [J]. MOLECULAR PSYCHIATRY, 2024,
  • [25] Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease
    Shimohama, S
    Kamiya, S
    Taniguchi, T
    Akagawa, K
    Kimura, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 239 - 242
  • [26] Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer's Disease
    Perdigao, Catarina
    Barata, Mariana A.
    Araujo, Margarida N.
    Mirfakhar, Farzaneh S.
    Castanheira, Jorge
    Guimas Almeida, Claudia
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [27] Key Role of Mitochondria in Alzheimer's Disease Synaptic Dysfunction
    Cavallucci, Virve
    Ferraina, Caterina
    D'Amelio, Marcello
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (36) : 6440 - 6450
  • [28] Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
    Chen, Yu
    Fu, Amy K. Y.
    Ip, Nancy Y.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2019, 195 : 186 - 198
  • [29] The contribution of glia to synaptic dysfunction at the onset of Alzheimer's disease
    Kater, M. S. J.
    Smit, A. B.
    Verheijen, M. H. G.
    [J]. GLIA, 2019, 67 : E350 - E350
  • [30] Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations
    Li, Ke
    Wei, Qing
    Liu, Fang-Fang
    Hu, Fan
    Xie, Ao-ji
    Zhu, Ling-Qiang
    Liu, Dan
    [J]. MOLECULAR NEUROBIOLOGY, 2018, 55 (04) : 3021 - 3032